SANDRA MCCOY: Open Payments
NPI 1083645998 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,308 in 44 payments from 20 companies in 2025. Trend: 2023 $2,875 · 2024 $3,003 · 2025 $3,308
Food & beverage: $3,308
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $568 |
| Novo Nordisk Inc | 8 | $434 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $388 |
| Lilly USA, LLC | 4 | $368 |
| Astellas Pharma US Inc | 4 | $167 |
| Phathom Pharmaceuticals, Inc. | 2 | $137 |
| Abbott Laboratories | 1 | $127 |
| SANOFI-AVENTIS U.S. LLC | 1 | $124 |
| Dexcom, Inc. | 1 | $123 |
| GENZYME CORPORATION | 1 | $122 |
Products named: Wegovy, KRYSTEXXA, KISUNLA, EVENITY, Veozah, VOQUEZNA, FREESTYLE LIBRE 3, TZIELD.
Industry payments across TX — which companies pay providers there.
